MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0137004
Chemino Pharma Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹243.26 Cr
▲ 4% YoY
Net profit · FY 2025
₹3.14 Cr
Net margin 1.3%
EBITDA · FY 2025
₹15.31 Cr
EBITDA margin 6.3%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹24.6 Cr
Issued & subscribed
Open charges
₹97.19 Cr
Satisfied ₹35 Cr
Company age
8 yrs
Est. 2018
Employees · EPFO
25
Provident fund records
About Chemino Pharma Limited
Data last updated:
Chemino Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33100MH2018PLC313189. Its GSTIN is 27AAECI9692P1ZJ (Maharashtra). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹24.6 Cr. It was formerly known as Chemino Pharma Private Limited and Insunt Trading Private Limited. It is led by directors including Sadashiv Kanyana Shetty (Managing Director) and Shriraj Sadashiv Shetty (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹243.26 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹3.14 Cr (net margin 1.3%) and EBITDA of ₹15.31 Cr (EBITDA margin 6.3%). Revenue has grown at a compounded annual rate (CAGR) of 398% over three years and 107% over five years.
The company has about 25 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Chemino Pharma. As per MCA filings, the company has open charges of ₹97.19 Cr and satisfied charges of ₹35 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 1 deal on record (1 rights issue); the latest was in March 2022. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Univentis Medicare Limited with revenue of ₹250.9 Cr.
Chemino Pharma Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0137004). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cheminopharma.com.
Company Details of Chemino Pharma Limited
CIN U33100MH2018PLC313189
Registration Number 313189
Incorporation Date 29 August 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0137004
Name History of Chemino Pharma Limited
Chemino Pharma has undergone 2 name changes throughout its history. The company was previously known as Chemino Pharma Private Limited, and Insunt Trading Private Limited. The current legal name is Chemino Pharma Limited.
| Company Name | Status |
|---|---|
| Chemino Pharma Limited | Current |
| Chemino Pharma Private Limited | Previous |
| Insunt Trading Private Limited | Previous |
CIN History of Chemino Pharma Limited
Chemino Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U33100MH2018PLC313189, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33100MH2018PLC313189 | Current |
| U33100MH2018PTC313189 | Previous |
| U71290MH2018PTC313189 | Previous |
Key People
Sadashiv Kanyana Shetty Managing Director Shriraj Sadashiv Shetty Whole-Time Director Shreya Sadashiv Shetty Director Recognitions & Rankings of Chemino Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressOffice No. 303 3rd Floor Western Edge 1 C.T.S. No 163 &165 – A Dattapada Road Borivali East, Magathane, Mumbai, Maharashtra, India – 400066
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Chemino Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Chemino Pharma Limited
Chemino Pharma operates one associated brand: Chemino Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of pharmaceutical APIs, intermediates, and solvents in India. | cheminopharma.com |
Business Activity of Chemino Pharma Limited
The main business activity of Chemino Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Chemino Pharma Limited FY 2025 filings available
Chemino Pharma Limited reported revenue of ₹243.26 Cr (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹243.26 Cr ▲ 4%
Net profit · FY 2025
₹3.14 Cr margin 1.3%
EBITDA · FY 2025
₹15.31 Cr margin 6.3%
Compounded Annual Growth Rate (CAGR) of Chemino Pharma Limited
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 398%
5 years · compounded
▲ 107%
EBITDA CAGR growth
1 year
▲ 60%
3 years · compounded
▲ 162%
5 years · compounded
▲ 20%
Revenue has grown at a compounded annual rate (CAGR) of 107% over five years, including 4% growth in the latest year. EBITDA rose 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Chemino Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹15.31 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.14 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Chemino Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Chemino Pharma are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Chemino Pharma Limited
Chemino Pharma has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shreya Sadashiv Shetty Also directs: Heranba Crop Care Private Limited | Director | 27 Oct 2021 | 4 Years 11 Months | Current |
| Shriraj Sadashiv Shetty | Whole-Time Director | 29 Aug 2018 | 8 Years 1 Months | Current |
| Sadashiv Kanyana Shetty Also directs: Daikaffil Chemicals India Limited, Heranba Industries Limited, Heranba Organics Private Limited and 3 more | Managing Director | 29 Aug 2018 | 8 Years 1 Months | Current |
| Meghraj Shetty Also directs: Heranba Agro Science Limited | Director | 01 Apr 2023 | 3 Years 6 Months | Current |
| Chandan Dashrathsingh Rajpurohit Also directs: Sarva Adviserium Private Limited | Director | 20 Mar 2025 | 1 Years 7 Months | Current |
| Kiran Parmanand Goklani Also directs: Sarva Adviserium Private Limited | Director | 20 Feb 2025 | 1 Years 8 Months | Current |
Peer Comparison of Chemino Pharma Limited
Chemino Pharma Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Univentis Medicare Limited | ₹250.9 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Panvel, Maharashtra, India |
| East India Pharmaceutical Works Limited | ₹249.94 Cr (FY 2024) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Aet Laboratories Private Limited | ₹246.84 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Sangareddy, Telangana, India |
| Icpa Health Products Ltd | ₹246.81 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Mumbai, Maharashtra, India |
| Vivek Pharmachem (India) Limited | ₹245.53 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Jaipur, Rajasthan, India |
| Chemino Pharma Limited this company | ₹243.26 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Blue Circle Organics Private Limited | ₹243.24 Cr (FY 2019) | •••• | •••• | 35.0% | •••• | Mumbai, Maharashtra, India |
| Khandelwal Laboratories Private Limited | ₹240.41 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
| JPB Chemical Industries Private Limited | ₹239.88 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Mumbai, Maharashtra, India |
| Ideal Cures Private Limited | ₹239.81 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
| Healthcaps India Limited | ₹239.43 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Fatehpur, Punjab, India |
Peers are the five companies nearest above and the five nearest below Chemino Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Chemino Pharma Limited
Chemino Pharma Limited is audited by GRANDMARK & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GRANDMARK & Associates | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Chemino Pharma Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Chemino Pharma Limited
Open charges
₹97.19 Cr
Satisfied charges
₹35 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2025 | Others | ₹1.46 Cr | Open |
| 28 Mar 2024 | Others | ₹87 Lakh | Open |
| 28 Mar 2024 | Others | ₹9.13 Cr | Open |
| 25 Oct 2022 | Hdfc Bank Limited | ₹72.93 Lakh | Open |
| 27 Jul 2022 | Others | ₹85 Cr | Open |
Total charge records: 6 View all charges
Deals & Funding of Chemino Pharma Limited
Chemino Pharma Limited has 1 deal on record (1 rights issue); the latest was in March 2022.
Total deals
1
Rights issue
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Rights issue | ₹22.99 Cr | Investors: 4 individuals |
Premium access
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Chemino Pharma Limited
Chemino Pharma Limited has 1 court case on record: 1 filed by Chemino Pharma. All case is pending. Status as checked on 04 Oct 2026.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Gujarat | Special civil application | Filed by the company against Gujarat Industrial Development Corporation | Pending |
Premium access
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Chemino Pharma Limited
Chemino Pharma Limited has a workforce of 25 employees as of Apr 06, 2024.
Employee count
25
Active EPFO establishments
1
Employee growth
13.64%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Chemino Pharma Limited
Chemino Pharma Limited has 8 board changes on record since 2018: 7 appointments and 1 cessation. The latest: Chandan Dashrathsingh Rajpurohit was appointed as Director on 20 Mar 2025.
AGM
Chemino Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 1.46 Cr with Charge ID 101164885 was registered on 18 Sep 2025.
Filing
Chemino Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Chandan Dashrathsingh Rajpurohit was appointed as Director.
Appointed
Kiran Parmanand Goklani was appointed as Director.
Charges
A charge with Others of Rs. 85.00 Cr registered on 27 Jul 2022 with Charge ID 100603885 was modified on 30 Nov 2024.
Charges
A charge with Others amounted to Rs. 0.87 Cr with Charge ID 100904654 was registered on 28 Mar 2024.
Charges
A charge with Others of Rs. 0.87 Cr registered on 28 Mar 2024 with Charge ID 100904654 was modified on 28 Mar 2024.
Charges
A charge with Others amounted to Rs. 9.13 Cr with Charge ID 100904659 was registered on 28 Mar 2024.
Charges
A charge with Others of Rs. 9.13 Cr registered on 28 Mar 2024 with Charge ID 100904659 was modified on 28 Mar 2024.
Appointed
Meghraj Shetty was appointed as Director.
Ceased
Kalpesh Balwantbhai Donga ceased to be Director.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Chemino Pharma Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Chemino Pharma Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Chemino Pharma Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Chemino Pharma Limited
Chemino Pharma has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECI9692P1ZJ | Maharashtra | Active | 05 Feb 2019 |
| 24AAECI9692P1ZP | Gujarat | Active | 28 Dec 2022 |
| 24AAECI9692P2ZO | Gujarat | Active | 06 Mar 2023 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Chemino Pharma Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chemino Pharma Limited
Chemino Pharma is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 August 2018 (8+ years old) and is registered under CIN U33100MH2018PLC313189.
Chemino Pharma reported revenue of ₹243.26 Cr for FY 2025 (up 4% YoY).
Chemino Pharma has 6 current directors:
- Sadashiv Kanyana Shetty - Managing Director
- Shriraj Sadashiv Shetty - Whole-Time Director
- Shreya Sadashiv Shetty - Director
- Meghraj Shetty - Director
- Chandan Dashrathsingh Rajpurohit - Director
- Kiran Parmanand Goklani - Director
Chemino Pharma reported a net profit of ₹3.14 Cr (net margin 1.3%) and EBITDA of ₹15.31 Cr (EBITDA margin 6.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Chemino Pharma is 398% over three years and 107% over five years. In the latest year (FY 2025) revenue rose 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Chemino Pharma is 27AAECI9692P1ZJ, registered in Maharashtra. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 24AAECI9692P1ZP (Gujarat), 24AAECI9692P2ZO (Gujarat).
The CIN (Corporate Identification Number) of Chemino Pharma is U33100MH2018PLC313189. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chemino Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
Chemino Pharma was incorporated on 29 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Chemino Pharma has 1 deal on record (1 rights issue); the latest was in March 2022.
The peers of Chemino Pharma by revenue are Univentis Medicare Limited, East India Pharmaceutical Works Limited, Aet Laboratories Private Limited, Icpa Health Products Ltd, Vivek Pharmachem (India) Limited and 5 more, all in the Pharma industry (Formulations).